Low levels of circulating estrogen sensitize PTEN-null endometrial tumors to PARP inhibition in vivo

Deanna M. Janzen, Daniel Y. Paik, Miguel A. Rosales, Brian Yep, Donghui Cheng, Owen N. Witte, Huseyin Kayadibi, Christopher M. Ryan, Michael E. Jung, Kym Faull, and Sanaz Memarzadeh

Tuesday, November 12, 2013
Published in Molecular Cancer Therapeutics